食管癌短程与长程姑息放疗比较:单中心观察性队列研究
该单中心回顾性队列研究分析了2009—2013年128例接受姑息外照射放疗的食管癌患者,比较短程方案(20 Gy/4 Gy/日,连续5个工作日)与长程方案(30–39 Gy/3 Gy,10–13个连续工作日)的疗效与毒性。两组吞咽困难缓解率及总生存无显著差异,但短程组急性食管炎和恶心/呕吐发生率显著更低。
要点
- 短程与长程姑息放疗的吞咽困难缓解率无显著差异(30.8% vs 22.0%,p=0.341)。
- 短程组急性食管炎(35.4% vs 56.0%,p=0.027)和恶心/呕吐(18.5% vs 36.0%,p=0.034)显著更少。
- 两组总生存无差异,短程组再干预有增多趋势(32.0% vs 18.9%,p=0.098)。
核心结论
- 短程与长程姑息放疗对食管癌吞咽困难的缓解效果相当,总生存无差异。
- 长程放疗急性毒性更频繁且更严重,短程方案耐受性更好且姑息效果等同。
研究设计与样本
- 单中心回顾性观察性队列研究,纳入2009年1月至2013年12月在卡罗林斯卡大学医院接受姑息外照射放疗的食管癌患者。
- 共128例患者,短程组75例(58.6%)接受20 Gy/4 Gy每日、连续5个工作日方案。
- 长程组53例(41.4%)接受30–39 Gy/3 Gy、10–13个连续工作日方案。
- 主要终点为吞咽困难缓解,次要终点为不良事件、再干预和总生存,采用Cox回归分析治疗安排对生存的影响。
主要发现
- 短程组急性毒性更少,食管炎发生率为35.4%对56.0%(p=0.027),恶心/呕吐为18.5%对36.0%(p=0.034)。
- 短程组再干预有增多趋势,为32.0%对18.9%(p=0.098)。
- 两组总生存无差异。
关键数值与推荐
- 短程姑息放疗方案:20 Gy分4次,每次4 Gy,每日一次,连续5个工作日。
- 长程姑息放疗方案:30–39 Gy分10–13次,每次3 Gy,连续10–13个工作日。
- 吞咽困难缓解率:短程组30.8%,长程组22.0%(p=0.341)。
- 急性食管炎发生率:短程组35.4%,长程组56.0%(p=0.027)。
- 恶心/呕吐发生率:短程组18.5%,长程组36.0%(p=0.034)。
临床怎么用
- 对于需姑息放疗的食管癌患者,短程方案(20 Gy/4 Gy/日×5天)可作为耐受性更好的选择,且吞咽困难缓解效果与长程相当。
- 选择长程方案时应警惕更高的急性食管炎和恶心/呕吐风险。
- 短程方案后再干预可能增多,临床随访中需关注。
局限性
- 本研究为单中心回顾性观察性队列研究,可能存在选择偏倚。
- 样本量有限(共128例),部分终点如再干预仅显示趋势未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Common symptoms of oesophageal cancer are dysphagia, pain, and bleeding. These symptoms can be relieved with palliative radiotherapy. The aim of this study was to analyse the outcome of two different palliative radiotherapy schedules. METHODS: We conducted a retrospective cohort study on palliative radiotherapy for oesophageal cancer given at Karolinska University Hospital. Patients included were treated with either short-course (20 Gy in 4 Gy fractions daily, 5 consecutive workdays) or long-course (30-39 Gy in 3 Gy fractions, 10-13 consecutive workdays) palliative external beam radiotherapy between January 2009 and December 2013. The primary endpoint was dysphagia relief and secondary endpoints were adverse events, re-interventions, and overall survival. Cox regression analyses were used to estimate the effect of treatment schedule on survival. RESULTS: A total of 128 patients received external beam radiotherapy under the study period, of these 75 (58.6%) received short-course radiotherapy and 53 (41.4%) long-course radiotherapy. Sixteen (30.8%) patients experienced dysphagia relief after short-course radiotherapy and 9 (22.0%) patients after long-course radiotherapy (p = 0.341). Acute toxicity was less frequent after short-course radiotherapy than after long-course radiotherapy, particularly oesophagitis (35.4% vs. 56.0%, p = 0.027) and nausea/emesis (18.5% vs. 36.0% p = 0.034). Re-interventions tended to be more common after short-course radiotherapy (32.0%) than after long-course radiotherapy (18.9%) (p = 0.098). There was no difference in overall survival between the two groups. CONCLUSIONS: Short- and long-course palliative radiotherapy for oesophageal cancer were equally effective to relieve dysphagia and no difference was seen in overall survival. Acute toxicity was, however, more frequent and more severe after long-course radiotherapy. Our results suggest that short-course radiotherapy is better tolerated with equal palliative effects as long-course radiotherapy.
引用
- Ólafsdóttir HS, Klevebro F, Ndegwa N, et al. Short-course compared to long-course palliative radiotherapy for oesophageal cancer: a single centre observational cohort study. Radiat Oncol. 2021. PMID: 34399793. doi:10.1186/s13014-021-01880-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。